Bettina Beyreuther

Title: Bettina Beyreuther: Innovator in Peptide Therapeutics

Introduction

Bettina Beyreuther is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of peptide therapeutics, holding a total of 3 patents. Her work focuses on developing innovative treatments for various medical conditions, particularly those related to hyperexcitability disorders and pain management.

Latest Patents

Bettina's latest patents include groundbreaking inventions aimed at addressing critical health issues. One of her notable patents is directed towards a therapy for hyperexcitability disorders, utilizing a class of peptide compounds to treat diseases associated with hyperexcitability and dysfunction of ion channels. Another significant patent involves methods for treating nucleoside-induced pain, specifically targeting tumor pain, bone cancer pain, and chemotherapy-induced pain through the use of peptide compounds.

Career Highlights

Throughout her career, Bettina has worked with esteemed companies such as UCB Pharma GmbH and Boehringer Ingelheim International GmbH. Her experience in these organizations has allowed her to advance her research and contribute to the development of effective therapeutic solutions.

Collaborations

Bettina has collaborated with notable professionals in her field, including Martin Hendrix and Lars Bärfacker. These partnerships have enriched her work and fostered innovation in peptide therapeutics.

Conclusion

Bettina Beyreuther's contributions to the field of peptide therapeutics are noteworthy, with her innovative patents addressing significant medical challenges. Her work continues to impact the healthcare industry positively.